Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

XERSXERS

Showing 0 of 11 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in XERIS PHARMACEUTICALS INC

As of its Q3 2021 13F, Susquehanna International Group held 609,527 shares of XERS (Xeris Pharmaceuticals), worth $1.5M. Susquehanna International Group's 13F filings listed XERS from Q2 2021 to Q3 2021, 2 quarterly filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used